Genetic and Expression Analysis of the SIRT1 Gene in Gastric Cancers.
- Author:
Zhang CAO
1
;
Jae Hwi SONG
;
Young Whi KANG
;
Jung Hwan YOON
;
Suk Woo NAM
;
Jung Young LEE
;
Won Sang PARK
Author Information
- Publication Type:Original Article
- Keywords: Gastric cancer; SIRT1; p53; Mutation; Immunohistochemistry
- MeSH: Adenine; Clinical Coding; Genes, p53; Immunohistochemistry; Lymph Nodes; Mammals; Mutation, Missense; Neoplasm Metastasis; Niacinamide; Stomach Neoplasms
- From:Journal of Gastric Cancer 2010;10(3):91-98
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Silent mating-type information regulation 2 homologue 1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent deacetylase. SIRT1 plays an important role in the regulation of cell death/survival and stress response in mammals. The aim of this study was to investigate whether the SIRT1 gene is involved in the development or progression of gastric cancers. MATERIALS AND METHODS: SIRT1 and p53 genes in 86 gastric cancers were examined for genetic alterations by PCR-single strand conformation polymorphism sequencing, as well as SIRT1 protein expression in 170 gastric cancers by immunohistochemistry. RESULTS: In the genetic analysis, we found SIRT1 and p53 mutations in two and 12 cases, respectively. Two missense mutations, c.599 C>T (T200I) and c.1258 G>A (E420K), were detected in the SIRT1 gene coding region. The SIRT1 and p53 mutation were found in mutually exclusive gastric cancers. The immunohistochemistry revealed that SIRT1 overexpression was found in 95 (55.9%) of 170 gastric cancers. Altered SIRT1 expression was not statistically associated with clinicopathological parameters, including tumor differentiation, location, lymph node metastasis, or p53 expression. Two cases with an SIRT1 mutation showed increased SIRT1 expression. CONCLUSIONS: These results suggest that genetic alterations and overexpression of the SIRT1 gene may contribute to gastric cancer development.
